Advocacy intelligence hub — real-time data for patient organizations
FINANCIAL LANDSCAPE SUMMARY
Total programs
Open now
Patient Assistance Programs4
ITVISMA
(ONASEMNOGENE ABEPARVOVEC-BRVE)Orphan drugNovartis Gene Therapies, Inc.
EVRYSDI
(RISDIPLAM)Orphan drugGenentech, Inc.
Zolgensma
(ONASEMNOGENE ABEPARVOVEC-XIOI)Orphan drugNovartis Gene Therapies, Inc.
Spinraza
(NUSINERSEN)Orphan drugBiogen Inc.
Chiara Marini-Bettolo, MD, PhD
Newcastle University
📍 Newcastle upon Tyne
Matthew ER Butchbach, Ph.D.
Nemours Children's Clinic
Philippe Latour
Service de Biochimie et Biologie Moléculaire
Byung-Ok Choi
Samsung Advanced Institute for Health Sciences & Technology
Ki Wha Chung
Kongju National University
Tanya Stojkovic
Nord/Est/Ile-de-France Neuromuscular Diseases Reference Centre